NEW MEDICINE Oncology Drug Development And Personalized Medicine Knowledgebase

LAKE FOREST, Calif., April 12, 2016 /PRNewswire/ -- New Medicine (http://www.newmedinc.com) has launched New Medicine's Oncology KnowledgeBASE (http://www.nmok.net), a highly disciplined relational database that provides a comprehensive view of the global oncology sector.   

nm|OK New Drugs and Marketed Drugs profiles
nm|OK provides detailed profiles of over 5,000 distinct drugs/in vivo imaging agents in development and on the market by:

  • developer/affiliate (over 1,000 pipelines)
  • generic name/brand name/other designation
  • technology/class
  • mechanism of action
  • cancer indications; over 100 indications
  • clinical indications; hundreds of indications
  • administration route
  • molecular target
  • biomarker/companion diagnostics
  • delivery technology
  • preclinical development status
  • clinical development by phase and status
  • clinical history, including trial protocols, interim and final results
  • sales history (when available)

Sample New Drug record
Sample Marketed Drug record

nm|OK Company profiles
nm|OK profiles over 2,250 companies in the oncology space in terms of:

  • history
  • management
  • financing
  • enabling technologies
  • affiliations/collaborations/licenses
  • pipelines, etc.

Sample Company records

nm|OK Targets in Oncology profiles
nm|OK profiles over 1,000 molecular targets implicated in cancer and its treatment in terms of:

  • cancer indication
  • utility (treatment, in vivo imaging, in vitro diagnosis, prognosis, disease monitoring, etc.
  • institution

Sample Target record

To contact New Medicine, request a no-obligation 2-week access to nm|OK or to order nm|OK, please visit http://www.newmedinc.com.

 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/oncology-drug-development-and-personalized-medicine-knowledgebase-300249734.html

SOURCE New Medicine

Back to news